What's New
Front Page
“New York Times” Article Examines Prevalence Rate and Diagnostic Challenges of Young-Onset Dementia
The New York Times highlighted a recent study underlining the high prevalence rate of young-onset dementia and…
ADDF and AFTD Partner to Support Wave Life Sciences’ FTD and ALS Clinical Program
AFTD and the Alzheimer’s Drug Discovery Foundation (ADDF) announced today that they have partnered to support Wave…
Dementia Educator Creates Children’s Book for Families Affected by Dementia
Certified Dementia Practitioner Doreen Coulson Putnam has applied her decades of experience in dementia education into writing…
Does It Run in the Family?: The Genetics of FTD
Partners in FTD Care, Winter 2022 Download the full issue (pdf) Most cases of FTD are sporadic,…
Genetic Counselor Discusses Significance of Genetic Testing in “Narrative Matters” Podcast
Genetic counselor Shivani Nazareth discussed in a recent episode of the Narrative Matters podcast why she advocated…
Newly Developed Apps Detect Speech Changes Associated with FTD
Researchers have developed apps that use artificial intelligence to detect subtle speech changes that may suggest the…
Webinar: The Role of Occupational Therapy in FTD Care
What is occupational therapy, and how can it best support individuals and families living with FTD? For…
All In for the Next Family
“This disease can be so insidious. Telling your story over and over, only to have no one…
Spotlight on…Dr. Joseph C. Marquez, AFTD Board of Directors
Joseph C. Marquez, M.D., joined AFTD’s Board of Directors earlier this year. The founder and head of…